Prognostic implications of loss of heterozygosity in the 17q21 region in breast cancer

被引：0
|
作者：
Gomendio, B
Silva, JM
Provencio, M
Garcia, JM
GarciaPatino, E
GarciaAndrade, C
Carretero, L
Espana, P
Bonilla, F
机构：
[1] CLIN TRABAJO,MOL GENET UNIT,MADRID 28003,SPAIN
[2] CLIN PUERTA DE HIERRO,DEPT MED ONCOL,MADRID 28035,SPAIN
[3] HOSP SANTA CRISTINA,DEPT PATHOL,E-28009 MADRID,SPAIN
[4] HOSP GEN GREGORIO MARANON,DEPT PATHOL,MADRID 28009,SPAIN
来源：
INTERNATIONAL JOURNAL OF ONCOLOGY | 1997年 / 10卷 / 03期
关键词：
loss of heterozygosity; breast cancer; BRCA1; locus; 17q21; region; prognostic factors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sporadic breast cancer is the commonest form of this malignancy. Genetic changes are frequent events in breast cancer. We investigated the implication of LOH in the 17q21 region as a prognostic factor in this disease. Fifty-three patients were studied and 14 clinico-pathological parameters were evaluated for comparison between the patients with LOH and patients without LOH. A LOH rate of 21% was found and, upon comparison of the two subgroups, a significantly lower rate of recurrence after adjuvant chemotherapy in patients with LOH was observed. This suggests that LOH occurring in this region in breast cancer could help to design new adjuvant treatment strategies.
引用
收藏
页码：659 / 663
页数：5
相关论文
共 50 条
  • [1] Loss of heterozygosity in the 17q21 region in breast cancer: clinical correlation
    GarciaPatino, E
    Gomendio, B
    Provencio, M
    Silva, JM
    Garcia, JM
    Lianes, P
    Palacios, J
    Espana, P
    Bonilla, F
    BREAST, 1997, 6 (05): : P903 - P903
  • [2] Loss of heterozygosity in the 17q21 region, microsatellite instability and oncogenic alterations in colon cancer.
    Cajal, SRY
    Lleonart, M
    GarciaPatino, E
    Sanchez, R
    Martin, P
    Moreno, A
    Bonilla, F
    LABORATORY INVESTIGATION, 1997, 76 (01) : 354 - 354
  • [3] Candidate target genes for loss of heterozygosity on human chromosome 17q21
    DeMarchis, L
    Cropp, C
    Sheng, ZM
    Bargo, S
    Callahan, R
    BRITISH JOURNAL OF CANCER, 2004, 90 (12) : 2384 - 2389
  • [4] Candidate target genes for loss of heterozygosity on human chromosome 17q21
    L DeMarchis
    C Cropp
    Z M Sheng
    S Bargo
    R Callahan
    British Journal of Cancer, 2004, 90 : 2384 - 2389
  • [5] THE HUMAN PLAKOGLOBIN GENE LOCALIZES ON CHROMOSOME 17Q21 AND IS SUBJECTED TO LOSS OF HETEROZYGOSITY IN BREAST AND OVARIAN CANCERS
    ABERLE, H
    BIERKAMP, C
    TORCHARD, D
    SEROVA, O
    WAGNER, T
    NATT, E
    WIRSCHING, J
    HEIDKAMPER, C
    MONTAGNA, M
    LYNCH, HT
    LENOIR, GM
    SCHERER, G
    FEUNTEUN, J
    KEMLER, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) : 6384 - 6388
  • [6] The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers
    Aberle, H.
    Bierkamp, C.
    Torchard, D.
    Serova, O.
    Proceedings of the National Academy of Sciences of the United States of America, 92 (14):
  • [7] Erratum: Candidate target genes for loss of heterozygosity on human chromosome 17q21
    L DeMarchis
    C Cropp
    Z M Sheng
    S Bargo
    R Callahan
    British Journal of Cancer, 2004, 91 : 1001 - 1001
  • [8] Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer
    Semba, S
    Yokozaki, H
    Yasui, W
    Tahara, E
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 12 (06) : 1245 - 1251
  • [9] BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer
    Uchida, T
    Wang, CX
    Sato, T
    Gao, J
    Takashima, R
    Irie, A
    Ohori, M
    Koshiba, K
    INTERNATIONAL JOURNAL OF CANCER, 1999, 84 (01) : 19 - 23
  • [10] Abnormal frequencies of alleles in polymorphic markers of the 17q21 region is associated with breast cancer
    Silva, JM
    Garcia, JM
    Gonzalez, R
    Dominguez, G
    Jareño, E
    Palacios, J
    Navarro, F
    Provencia, M
    España, P
    Bonilla, F
    CANCER LETTERS, 1999, 138 (1-2) : 209 - 215
12345